Shopping Cart
- Remove All
- Your shopping cart is currently empty
ATX inhibitor 5 is a potent and orally active autotaxin (ATX) inhibitor (IC50: 15.3 nM) that reduces CCl4-induced hepatic fibrosis and exhibits anti-hepatic fibrosis effects.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $97 | In Stock | |
5 mg | $239 | In Stock | |
10 mg | $383 | In Stock | |
25 mg | $653 | In Stock | |
50 mg | $893 | In Stock | |
100 mg | $1,220 | In Stock | |
1 mL x 10 mM (in DMSO) | $249 | In Stock |
Description | ATX inhibitor 5 is a potent and orally active autotaxin (ATX) inhibitor (IC50: 15.3 nM) that reduces CCl4-induced hepatic fibrosis and exhibits anti-hepatic fibrosis effects. |
Targets&IC50 | Stellate cells:0.78 μM, Fibroblasts (cardiac):1.21 μM, ATX:15.3 nM |
In vitro | ATX inhibitor 5 (10 μM) successfully suppresses collagen content induced by TGF-β.[1] |
In vivo | ATX inhibitor 5 (20-40 mg/kg/d, p.o., two weeks) significantly reduces CCl4-induced hepatic fibrosis levels.[1] |
Molecular Weight | 474.87 |
Formula | C22H18ClF3N6O |
Cas No. | 2402772-45-4 |
Smiles | FC(F)(F)c1cccc(Nc2ncnc3CCN(Cc23)C(=O)N\N=C\c2ccc(Cl)cc2)c1 |
Relative Density. | 1.45 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 225.0 mg/mL (473.8 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.